Please sign in to follow a disease.

Complement-mediated kidney disease

Clinical trials for Complement-mediated kidney disease explained in plain language.

Never miss a new study

Get alerted when new Complement-mediated kidney disease trials appear

Sign up with your email to follow new studies for Complement-mediated kidney disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1

New study to map Real-World use of iptacopan in rare kidney disease

Knowledge-focused Not yet recruiting

This study looks back at medical records of about 83 adults with C3 glomerulopathy (C3G), a rare kidney disease, who are taking the drug iptacopan. Researchers will describe patients' health history, lab results, and how their disease changes over a year of treatment. The goal is…

Matched conditions: COMPLEMENT-MEDIATED KIDNEY DISEASE

Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:09 UTC

Complement-mediated kidney disease

Get alerted when new Complement-mediated kidney disease trials appear

New study to map Real-World use of iptacopan in rare kidney disease